A Multiple-Dose, Open-Label, Phase 1, Pharmacokinetic, Pharmacodynamic, and Safety Study of Avonex in Chinese Healthy Volunteer Subjects
Phase of Trial: Phase I
Latest Information Update: 08 Jun 2015
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis; Ulcerative colitis
- Focus Pharmacokinetics
- 03 Nov 2011 Actual end date (October 2011) added as reported by ClinicalTrials.gov.
- 01 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Sep 2011 Actual initiation date (August 2011) added as reported by ClinicalTrials.gov.